A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration.
A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
Surgical patients who have recently had COVID-19 are more likely to develop potentially fatal post-operative blood clots, a new global study reveals.
A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
Researchers from the University of Birmingham have confirmed the speed, accuracy and simplicity of a novel, highly sensitive testing method for COVID-19.
Patients isolating before surgery - mainly to avoid COVID-19 and its complications – are at a 20% increased risk of developing post-operative lung complications compared with patients who do not isolate.
The most comprehensive study so far of genetic diversity in the Middle East has given a glimpse into the lives of ancient humans who lived through seismic events including the formation of the Arabian Desert.
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.